Uta Ishikawa

Uta Ishikawa

Higher Degree by Research Candidate

South Australian Immunogenomics Cancer Institute

Faculty of Health and Medical Sciences

Holds a Bachelor’s degree in Biomedical Sciences from the Federal University of Rio Grande do Norte, Brazil, with a background in undergraduate research on cancer and inflammation, focusing on nanoparticle-based cancer therapy.

Currently pursuing a Master’s degree by research at the South Australian Immunogenomics Cancer Institute (SAIGENCI), within the BioImmunoEngineering Laboratory (BIEL). Research focuses on the development of lipid-polymer nanodiscs for mRNA delivery in cancer immunotherapy, aiming to enhance therapeutic efficacy.

Research interests include nanomedicine, immunotherapy, and drug delivery systems, particularly in oncology.

  • Journals
    Year Citation
    2023 Holandaa, A. G. A., Cesario, B. C., Silva, V. M., Francelino, L. E. C., Nascimento, B. H. M., Damascenoa, K. F. A., . . . Queiroza, G. F. (2023). Use of Cold Atmospheric Plasma in the Treatment of Squamous Cell Carcinoma:<i> in</i><i> vitro</i> Effects and Clinical Application in Feline Tumors: A Pilot Study. TOPICS IN COMPANION ANIMAL MEDICINE, 53-54, 10 pages.
    DOI
    2022 Silva, F. S., Costa de Souza, K. S., Galdino, O. A., de Moraes, M. V., Ishikawa, U., Medeiros, M. A., . . . de Oliveira, M. F. (2022). Hyperbaric oxygen therapy mitigates left ventricular remodeling, upregulates MMP-2 and VEGF, and inhibits the induction of MMP-9, TGF-β1, and TNF-α in streptozotocin-induced diabetic rat heart. LIFE SCIENCES, 295, 10 pages.
    DOI
    2021 Cavalcante, R. S., Ishikawa, U., Silva, E. S., Silva-Junior, A. A., Araujo, A. A., Cruz, L. J., . . . de Araujo Junior, R. F. (2021). STAT3/NF-κB signalling disruption in M2 tumour-associated macrophages is a major target of PLGA nanocarriers/PD-L1 antibody immunomodulatory therapy in breast cancer. BRITISH JOURNAL OF PHARMACOLOGY, 178(11), 2284-2304.
    DOI Europe PMC35
Connect With Me
External Profiles